Impact of Interferon Lambda 4 Genotype on Interferon‐Stimulated Gene Expression During Direct‐Acting Antiviral Therapy for Hepatitis C

New directly acting antivirals (DAAs) provide very high cure rates in most patients infected by hepatitis C virus (HCV). However, some patient groups have been relatively harder to treat, including those with cirrhosis or infected with HCV genotype 3. In the recent BOSON trial, genotype 3, patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramamurthy, Narayan, Marchi, Emanuele, Ansari, M. Azim, Pedergnana, Vincent, Mclean, Angela, Hudson, Emma, Bowden, Rory, Spencer, Chris C.A., Barnes, Eleanor, Klenerman, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207923/
https://www.ncbi.nlm.nih.gov/pubmed/29534310
http://dx.doi.org/10.1002/hep.29877

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207923/
https://www.ncbi.nlm.nih.gov/pubmed/29534310
http://dx.doi.org/10.1002/hep.29877

Ejemplares similares